PharmaReports: Immunology & Inflammatory Diseases
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports relating to inflammatory diseases and organ transplant are featured in this channel. Articles on osteoarthritis are also featured here. Reports focusing on immunological approaches to other disease states can also be included in this channel.
Showing results 101 - 150 of 215
- Commercial Insight: Asthma and COPD
- Stakeholder Insight: Osteoarthritis - COX-2s wear down traditional NSAID use
- Stakeholder Insight: Rheumatoid Arthritis - DMARDs Gain Ground as Biologics Competition Intensifies
- Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There Life After Claritin?
- Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics
- Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share
- Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage Pipeline Leaves Innovation to
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics
- The Worldwide Market for Prescription Dermatological Drugs - 4th Edition
- Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
- Gene Expression Profiling Markets
- Organ Transplant Immunosuppressive Markets
- The World Dermatological Market Analysis & Forecasts 2007-2022
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Inflammatory Bowel Disease - Debate over early aggressive treatment continues
- How to Conduct Clinical Trials in China
- Prescription Dermatological Drugs: Worldwide Market
- Worldwide Market for Rheumatoid Arthritis and Lupus Treatments
- Alpha 1 Antitrypsin Deficiency
- Commercial Insight: Autoimmune Diseases - Market continues to prosper
- Launching Combination Products: Brand extension and franchise development strategies
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Portable Inhaler Devices - Current Market and Life Cycle Opportunities
- Outsourcing in Drug Discovery
- World OTC Pharmaceutical Markets
- World Wound Care Markets 2008 - Burns, Skin Ulcers, Surgical and Trauma Wounds
- Respiratory Market Insight 2008
- The osteoarthritis market - COX-2 inhibibitors, NSAIDs and corticosteroids
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- World Wound Care Markets 2008
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- World Market for Respiratory Equipment and Disposables
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma
- Asthma/COPD - Little long-term future for long-acting single-agent inhalers
- Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments
- Stakeholder Opinions: Vaccine adjuvants
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development